Julian Robertson' Tiger Management Buys LYB, VRX, PETD, QCOM, Sells ALVR

Author's Avatar
Feb 14, 2011
Article's Main Image
Legendary hedge fund manager Julian Robertson reported his 4th quarter portfolio. As of 12/31/2010, Tiger Management owns 26 stocks with a total value of $390 million. These are the details of the buys and sells.

This is the portfolio chart of Julian Robertson. You can click on the legend of the chart to show/hide buys, sells, or holdings. Each ball on the chart represents a position in the portfolio. You can move your mouse on the balls to see the details of each position and click to see the details of all guru trades with this position.



For the details of Julian Robertson's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Julian+Robertson

This is the sector weightings of his portfolio:

Technology

27.1%

Financials

20.9%

Health Care

16.7%

Oil & Gas

12.9%

Consumer Services

10.5%

Consumer Goods

5.1%

Industrials

0.5%



These are the top 5 holdings of Julian Robertson

  1. Apple Inc. (AAPL) - 121,830 shares, 10.07% of the total portfolio. Shares reduced by 4.51%
  2. LYONDELLBASELL IND NV ORD SHS CL A (LYB) - 719,000 shares, 6.34% of the total portfolio. Shares added by 10000%
  3. Google Inc. (GOOG) - 41,150 shares, 6.26% of the total portfolio. Shares added by 8.43%
  4. The Goldman Sachs Group Inc. (GS) - 137,300 shares, 5.92% of the total portfolio. Shares reduced by 19.14%
  5. VISA INC. (V) - 307,000 shares, 5.54% of the total portfolio. Shares added by 31.76%


New Purchase: Lyondellbasell Ind Nv Ord Shs Cl A (LYB, Financial)

Julian Robertson initiated holdings in Lyondellbasell Ind Nv Ord Shs Cl A. His purchase prices were between $26 and $33.76, with an estimated average price of $29.39. The impact to his portfolio due to this purchase was 6.34%. His holdings were 719,000 shares as of 12/31/2010.

LyondellBasell Industries AF S.C.A is a manufactures chemicals and derivatives. Lyondellbasell Ind Nv Ord Shs Cl A has a market cap of $20.97 billion; its shares were traded at around $37.07 .

New Purchase: Valeant Pharmaceuticals International (VRX, Financial)

Julian Robertson initiated holdings in Valeant Pharmaceuticals International. His purchase prices were between $24.59 and $30.28, with an estimated average price of $27.13. The impact to his portfolio due to this purchase was 4.35%. His holdings were 600,000 shares as of 12/31/2010.

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International has a market cap of $12.16 billion; its shares were traded at around $40.54 with a P/E ratio of 34.95 and P/S ratio of 14.82. The dividend yield of Valeant Pharmaceuticals International stocks is 0.93%. Valeant Pharmaceuticals International had an annual average earning growth of 10.8% over the past 5 years.

New Purchase: Petroleum Development Corp. (PETD, Financial)

Julian Robertson initiated holdings in Petroleum Development Corp.. His purchase prices were between $27.96 and $42.35, with an estimated average price of $35.29. The impact to his portfolio due to this purchase was 4.11%. His holdings were 380,000 shares as of 12/31/2010.

Petroleum Development Corporation is an independent energy company engaged primarily in the development, production and marketing of natural gas and oil. Petroleum Development Corp. has a market cap of $1.06 billion; its shares were traded at around $46.56 with a P/E ratio of 172.44 and P/S ratio of 4.35. Petroleum Development Corp. had an annual average earning growth of 19.2% over the past 10 years.

New Purchase: Qualcomm Inc. (QCOM, Financial)

Julian Robertson initiated holdings in Qualcomm Inc.. His purchase prices were between $43.89 and $49.99, with an estimated average price of $47.04. The impact to his portfolio due to this purchase was 3.68%. His holdings were 290,000 shares as of 12/31/2010.

QUALCOMM Inc. develops and delivers innovative digital wireless communications products and services based on the company's CDMA digital technology. Qualcomm Inc. has a market cap of $93.18 billion; its shares were traded at around $57.6 with a P/E ratio of 25.6 and P/S ratio of 8.48. The dividend yield of Qualcomm Inc. stocks is 1.32%. Qualcomm Inc. had an annual average earning growth of 14.6% over the past 10 years. GuruFocus rated Qualcomm Inc. the business predictability rank of 3-star.

Added: Digitalglobe Inc. (DGI)

Julian Robertson added to his holdings in Digitalglobe Inc. by 216.04%. His purchase prices were between $28.71 and $32.95, with an estimated average price of $31.25. The impact to his portfolio due to this purchase was 2.19%. His holdings were 395,051 shares as of 12/31/2010.

DigitalGlobe, Inc. is a global provider of commercial high-resolution earth imagery products and services. Digitalglobe Inc. has a market cap of $1.38 billion; its shares were traded at around $29.96 with a P/E ratio of 74.9 and P/S ratio of 4.89.

Added: Visa Inc. (V)

Julian Robertson added to his holdings in Visa Inc. by 31.76%. His purchase prices were between $66.9 and $80.89, with an estimated average price of $75.87. The impact to his portfolio due to this purchase was 1.34%. His holdings were 307,000 shares as of 12/31/2010.

VISA operates the world's largest retail electronic payments network and is one of the most recognized global financial services brands. Visa Inc. has a market cap of $62.57 billion; its shares were traded at around $74.93 with a P/E ratio of 18.23 and P/S ratio of 7.76. The dividend yield of Visa Inc. stocks is 0.8%.

Added: Wuxi Pharmatech Inc. (WX)

Julian Robertson added to his holdings in Wuxi Pharmatech Inc. by 30.12%. His purchase prices were between $16.05 and $17.72, with an estimated average price of $16.77. The impact to his portfolio due to this purchase was 0.99%. His holdings were 1,036,572 shares as of 12/31/2010.

Shanghai-based WuXi PharmaTech is the China-based pharmaceutical and biotechnology R&D outsourcing company. Wuxi Pharmatech Inc. has a market cap of $1.12 billion; its shares were traded at around $15.69 with a P/E ratio of 18.68 and P/S ratio of 4.17.

Added: Cablevision Systems Corp. (CVC)

Julian Robertson added to his holdings in Cablevision Systems Corp. by 16.15%. His purchase prices were between $26.03 and $34.72, with an estimated average price of $30.05. The impact to his portfolio due to this purchase was 0.63%. His holdings were 525,000 shares as of 12/31/2010.

Cablevision Systems Corp. is one of the nation's entertainment and telecommunications companies. Cablevision Systems Corp. has a market cap of $11.31 billion; its shares were traded at around $37.69 with a P/E ratio of 24.32 and P/S ratio of 1.45. The dividend yield of Cablevision Systems Corp. stocks is 1.33%. Cablevision Systems Corp. had an annual average earning growth of 6.8% over the past 10 years.

Added: Google Inc. (GOOG)

Julian Robertson added to his holdings in Google Inc. by 8.43%. His purchase prices were between $522.35 and $626.77, with an estimated average price of $590.4. The impact to his portfolio due to this purchase was 0.49%. His holdings were 41,150 shares as of 12/31/2010.

Google is a public and profitable company focused on search services. Google Inc. has a market cap of $199.7 billion; its shares were traded at around $624.5 with a P/E ratio of 23.75 and P/S ratio of 6.81. Google Inc. had an annual average earning growth of 58.4% over the past 10 years.

Added: Cardiome Pharma Corp. (CRME)

Julian Robertson added to his holdings in Cardiome Pharma Corp. by 9.55%. His purchase prices were between $4.6 and $6.55, with an estimated average price of $5.6. The impact to his portfolio due to this purchase was 0.34%. His holdings were 2,385,615 shares as of 12/31/2010.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function. Cardiome Pharma Corp. has a market cap of $365.7 million; its shares were traded at around $5.99 with a P/E ratio of 6.66 and P/S ratio of 6.69.

Sold Out: Alvarion Ltd. (ALVR, Financial)

Julian Robertson sold out his holdings in Alvarion Ltd.. His sale prices were between $1.84 and $2.76, with an estimated average price of $2.44.

Alvarion is a powerhouse of point-to-multipoint broadband wireless access (BWA) solutions for telecom carriers, service providers, and Enterprises worldwide. Alvarion Ltd. has a market cap of $113.05 million; its shares were traded at around $1.95 with and P/S ratio of 0.55.